Gene · 3912
Papers1,743
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
61 to 80 of 1,743
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Lamb1-mediated Wnt/β-catenin signaling pathway drives endothelial angiogenesis for fracture healing. | Gene | 2025 | 40221061 | PubTator, text mining | PubMed |
| Ultrasound-Responsive Polymeric Piezoelectric Nanoparticles for Remote Activation and Neuronal Differentiation of Human Neural Stem Cells. | Small Sci | 2025 | 40213071 | PubTator, text mining | PubMed |
| Role and Validation of Lactylation-Related Gene Markers in Postmenopausal Osteoporosis. | Appl Biochem Biotechnol | 2025 | 40131629 | PubTator, text mining | PubMed |
| Correction: LAMB1 downregulation suppresses glioma progression by inhibiting aerobic glycolysis through regulation of the NF-κB/HK2 axis. | Discov Oncol | 2025 | 40100451 | PubTator, text mining | PubMed |
| Ethoxychelerythrine as a potential therapeutic strategy targets PI3K/AKT/mTOR induced mitochondrial apoptosis in the treatment of colorectal cancer. | Sci Rep | 2025 | 39994297 | PubTator, text mining | PubMed |
| LAMB1 downregulation suppresses glioma progression by inhibiting aerobic glycolysis through regulation of the NF-κB/HK2 axis. | Discov Oncol | 2025 | 39920513 | PubTator, text mining | PubMed |
| LAMB1 promotes proliferation and metastasis in nasopharyngeal carcinoma and shapes the immune-suppressive tumor microenvironment. | Braz J Otorhinolaryngol | 2025 | 39874810 | PubTator, text mining | PubMed |
| Nanodomain cAMP signaling in cardiac pathophysiology: potential for developing targeted therapeutic interventions. | Physiol Rev | 2025 | 39115424 | PubTator, text mining | PubMed |
| Vascular Basement Membrane Fragmentation in Keloids and the Expression of Key Basement Membrane Component Genes. | Plast Reconstr Surg Glob Open | 2024 | 39717721 | PubTator, text mining | PubMed |
| Downregulation of Genes for Skeletal Muscle Extracellular Matrix Components by Cisplatin. | Biol Pharm Bull | 2024 | 39522978 | PubTator, text mining | PubMed |
| Monogenic causes of cerebral small vessel disease and stroke. | Handb Clin Neurol | 2024 | 39322384 | PubTator, text mining | PubMed |
| The prognostic value of bioinformatics analysis of ECM receptor signaling pathways and LAMB1 identification as a promising prognostic biomarker of lung adenocarcinoma. | Medicine (Baltimore) | 2024 | 39312319 | PubTator, text mining | PubMed |
| Optical Genome Mapping Identifies a Second Xq27.1 Rearrangement Associated With Charcot-Marie-Tooth Neuropathy CMTX3. | Mol Genet Genomic Med | 2024 | 39305100 | PubTator, text mining | PubMed |
| Proteomics and Bioinformatics Identify Drug-Resistant-Related Genes with Prognostic Potential in Cholangiocarcinoma. | Biomolecules | 2024 | 39199357 | PubTator, text mining | PubMed |
| Using established biorepositories for emerging research questions: a feasibility study. | Clin Proteomics | 2024 | 39154002 | PubTator, text mining | PubMed |
| Biologically Relevant Laminin-511 Moderates the Derivation and Proliferation of Human Lens Epithelial Stem/Progenitor-Like Cells. | Invest Ophthalmol Vis Sci | 2024 | 39106056 | PubTator, text mining | PubMed |
| [Clinical and bioinformatics analysis of the relationship between LAMA3 DNA methylation expression and platinum resistance and prognosis in epithelial ovarian cancer]. | Zhonghua Fu Chan Ke Za Zhi | 2024 | 38951081 | PubTator, text mining | PubMed |
| Identification of established and novel extracellular matrix components in glioblastoma as targets for angiogenesis and prognosis. | Neurogenetics | 2024 | 38775886 | PubTator, text mining | PubMed |
| Single cell sequencing data identify distinct B cell and fibroblast populations in stricturing Crohn's disease. | J Cell Mol Med | 2024 | 38685679 | PubTator, text mining | PubMed |
| Proteomic Identification of Small Extracellular Vesicle Proteins LAMB1 and Histone H4 for Prostate Cancer Diagnosis and Risk Stratification. | Adv Sci (Weinh) | 2024 | 38590132 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3912/papers?page=4